Showing results (71-80 of 326) with videos related to
Sort By:
Pageof 33
Human Psychopharmacology|October 23, 2021
How prevalent and severe is addiction on GABAmimetic drugs in an elderly German general hospital population? Focus on gabapentinoids, benzodiazepines, and z-hypnotic drugsUdo Bonnet, Heath B McAnallyEuropean Addiction Research|June 20, 2019
The Prescription of Anticraving Medication and its Economic ConsequencesRüdiger Holzbach, Gunnar Stammen, Ute Kirchhof, et al.Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|October 21, 2010
[Addicted anaesthetists]Christoph Maier, Judith Iwunna, Jens Soukup, et al.Substance Abuse Treatment, Prevention, and Policy|March 12, 2020
Implementation of opioid maintenance treatment in prisons in North Rhine-Westphalia, Germany - a top down approachKathrin Böhmer, Henrike Schecke, Irmgard Render, et al.Fortschritte Der Neurologie-Psychiatrie|June 24, 2017
[ADHD in Adults and Comorbid Substance Use Disorder: Prevalence, Clinical Diagnostics and Integrated Therapy]Henrike Dirks, Norbert Scherbaum, Bernhard Kis, et al.Clinical Neuropharmacology|November 11, 2014
Use of disulfiram for alcohol relapse prevention in patients in opioid maintenance treatmentMichael Specka, Martin Heilmann, Bodo Lieb, et al.The Journal of Dermatology|December 23, 2020
Psychological burden of psoriatic patients in a German university hospital dermatology departmentWiebke Sondermann, Oliver Fiege, Andreas Körber, et al.Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|July 2, 2020
[Scientific Rationale for the Directive on Opioid Substitution Treatment of the German Medical Association: A Summary]Wilfried Kunstmann, Michael Specka, Norbert Wodarz, et al.BMC Psychology|August 29, 2023
The impact of social connectedness on mental health in LGBTQ + identifying individuals during the COVID-19 pandemic in GermanyChristine Firk, Nicola Großheinrich, Norbert Scherbaum, et al.Substance Abuse Treatment, Prevention, and Policy|December 18, 2019
Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatmentJens Reimer, Tobias Vogelmann, Daniel Trümper, et al.Pageof 33